| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 105,802 | 107,931 | 104,683 | 103,556 | | Cost of Revenue | 31,895 | 34,086 | 32,679 | 30,711 | | | Gross Profit | 73,907 | 73,845 | 72,004 | 72,845 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,566 | 38,726 | 38,346 | 39,264 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 22,437 | 22,880 | 22,680 | 23,948 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,904 | 12,239 | 10,978 | 9,633 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (342) | 3,458 | 946 | 177 | | Earnings Before Interest And Taxes | (2,284) | 15,697 | 11,924 | 9,810 | | Interest Expense | 1,050 | 14,364 | 14,197 | 11,890 | | Income Before Tax | (3,334) | 1,333 | (2,273) | (2,080) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,756) | 1,333 | (2,273) | (2,080) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,334) | 1,333 | (2,273) | (2,080) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,334) | $1,333 | ($2,273) | ($2,080) |
|
0.02% Nasdaq 0.00%
Income Statement
